(ECL) Ecolab - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2788651006
ECL: Water Treatment, Cleaning Solutions, Sanitizing Products, Pest Elimination Services
Ecolab Inc. (NYSE:ECL) is a global leader in water, hygiene, and infection prevention solutions. Founded in 1923 and headquartered in Saint Paul, Minnesota, the company operates through three core segments: Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences. Its diverse product portfolio addresses critical needs across industries, from water treatment and process optimization to cleaning, sanitizing, and infection control.
The Global Industrial segment serves a wide range of industries, including manufacturing, food and beverage processing, transportation, chemical, metals, mining, power generation, and petrochemicals. Ecolab’s solutions here focus on water treatment, process applications, and cleaning technologies that enhance efficiency and sustainability. This segment is pivotal for industries where water scarcity and contamination are operational risks.
The Global Institutional & Specialty segment caters to the foodservice, hospitality, lodging, government, education, and retail sectors. Ecolab provides specialized cleaning and sanitizing products that are essential for maintaining public health and safety standards. This segment is deeply integrated into the daily operations of its customers, offering tailored solutions to prevent the spread of pathogens and ensure regulatory compliance.
The Global Healthcare & Life Sciences segment is a cornerstone of Ecolab’s business, serving healthcare, personal care, and pharmaceutical industries. Under brands like Ecolab, Microtek, and Anios, the company delivers infection prevention solutions, surgical products, and contamination control services. This segment is critical for healthcare facilities and life sciences companies, where maintaining sterile environments is paramount.
Ecolab also offers pest elimination services, addressing the detection, elimination, and prevention of rodents and insects in commercial settings such as restaurants, food processors, hotels, and grocery operations. Additionally, the company provides colloidal silica products used in semiconductor manufacturing, catalyst production, and aerospace components. Its portfolio is complemented by water and energy management programs, custom-designed wash process solutions, and real-time data management tools.
From a financial perspective, Ecolab is a large-cap company with a market capitalization of approximately $75.17 billion. Its current P/E ratio of 35.97 reflects its premium valuation,
Additional Sources for ECL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ECL Stock Overview
Market Cap in USD | 75,171m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1988-01-05 |
ECL Stock Ratings
Growth 5y | 33.4% |
Fundamental | 47.1% |
Dividend | 54.7% |
Rel. Strength Industry | 14 |
Analysts | 3.73/5 |
Fair Price Momentum | 234.67 USD |
Fair Price DCF | 50.27 USD |
ECL Dividends
Dividend Yield 12m | 0.89% |
Yield on Cost 5y | 1.20% |
Annual Growth 5y | 4.54% |
Payout Consistency | 96.7% |
ECL Growth Ratios
Growth Correlation 3m | 20.9% |
Growth Correlation 12m | 73% |
Growth Correlation 5y | 27.2% |
CAGR 5y | 6.25% |
CAGR/Mean DD 5y | 0.42 |
Sharpe Ratio 12m | 1.09 |
Alpha | 4.13 |
Beta | 0.83 |
Volatility | 18.18% |
Current Volume | 1265.2k |
Average Volume 20d | 1284.2k |
As of February 19, 2025, the stock is trading at USD 266.22 with a total of 1,265,218 shares traded.
Over the past week, the price has changed by +1.91%, over one month by +10.43%, over three months by +8.52% and over the past year by +24.23%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ecolab (NYSE:ECL) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.07 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECL as of February 2025 is 234.67. This means that ECL is currently overvalued and has a potential downside of -11.85%.
Ecolab has received a consensus analysts rating of 3.73. Therefor, it is recommend to hold ECL.
- Strong Buy: 8
- Buy: 4
- Hold: 13
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ECL Ecolab will be worth about 281.6 in February 2026. The stock is currently trading at 266.22. This means that the stock has a potential upside of +5.78%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 280.9 | 5.5% |
Analysts Target Price | 272.4 | 2.3% |
ValueRay Target Price | 281.6 | 5.8% |